CollPlant Biotechnologies (CLGN) Assets Average (2018 - 2026)

CollPlant Biotechnologies has reported Assets Average for 9 years, with the latest figure at $10.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 6.63% year-over-year to $10.0 million; the trailing twelve-month figure through Mar 2026 stood at $10.0 million (up 6.63% YoY), and the FY2025 full-year result was $14.7 million, down 44.18% from the prior year.
• Assets Average for Q1 2026 stood at $10.0 million, down from $12.4 million in the prior quarter.
• The five-year high for Assets Average was $50.0 million in Q1 2022, with the low at $8.7 million in Q2 2025.
• Historically, Assets Average has averaged $23.6 million across 5 years, with a median of $17.1 million in 2024.
• Annual changes were most pronounced in 2022 — Assets Average jumped 817.14% — and 2024, when it tumbled 65.61%.
• CollPlant Biotechnologies' Assets Average stood at $39.2 million in 2022, then sank by 56.38% to $17.1 million in 2023, then sank by 45.17% to $9.4 million in 2024, then jumped by 32.79% to $12.4 million in 2025, then dropped by 19.72% to $10.0 million in 2026.
• The last three Assets Average figures came in at $10.0 million (Q1 2026), $12.4 million (Q4 2025), and $15.8 million (Q3 2025), per Business Quant data.